Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp. (KTTA) has recorded 12 insider filings from 7 unique insiders, totaling $1.0M in trading activity (net buying). Insiders have purchased $150.0K and sold $0, reflecting a net buying posture that may signal internal confidence in the company's near-term prospects. The most active insider by volume is Marques Tiago. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.